Transforming growth factor beta-1 An important biomarker for developing cardiovascular diseases in chronic renal failure.
Bratisl Lek Listy
; 118(3): 175-178, 2017.
Article
em En
| MEDLINE
| ID: mdl-28319415
ABSTRACT
OBJECTIVE:
Our study focuses on the determination and evaluation of TGF-ß1 levels of patients receiving hemodialysis treatment because of chronic renal failure.BACKGROUND:
Chronic renal failure, characterized by irreversible loss of renal function, is a major public health problem in the world. Transforming growth factor-beta is a multifunctional cytokine involved in the cellular growth, differentiation, migration, apoptosis and immune regulation. Among the three TGF-ß isoforms, TGF-ß1 plays a key role in the pathogenesis of renal diseases.METHODS:
We studied 24 patients who were on regular hemodialysis, with non-diabetic nephropathy. 20 healthy people who proved to be in a good state of health and free from any signs of chronic diseases or disorders were enrolled as a control group. Serum samples were collected both before and after hemodialysis treatment from each patient. TGF-ß1 levels were determined by Enzyme Immunoassay method.RESULTS:
TGF-ß1 levels were found significantly higher in the hemodialysis patients than those of the control groups. Also, the TGF-ß1 was significantly reduced after hemodialysis treatment but it was still higher than in control groups.CONCLUSION:
This result indicates that hemodialysis is an effective treatment method to decrease the serum TGF-B1 levels. Nevertheless, this decrease is not enough to reduce existing risks (Tab. 1, Fig. 2, Ref. 28).Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Doenças Cardiovasculares
/
Diálise Renal
/
Fator de Crescimento Transformador beta1
/
Falência Renal Crônica
Tipo de estudo:
Observational_studies
/
Risk_factors_studies
Limite:
Humans
Idioma:
En
Revista:
Bratisl Lek Listy
Ano de publicação:
2017
Tipo de documento:
Article